On March 2, 2021 Vedanta Biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, reported that members of its executive team will present and host one-on-one meetings at the following virtual investor conferences (Press release, Vedanta Biosciences, MAR 2, 2021, View Source [SID1234575927]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Chardan 3rd Annual Microbiome Medicines Summit

Date: Monday, March 8, 2021

Presentation Time: 2:00 PM ET

H.C. Wainwright Global Life Sciences Conference

Date: Tuesday, March 9, 2021

Presentation Time: 7:00 AM ET

Credit Suisse 2021 Healthcare Innovators Series: Life Sciences Private Company Event

Date: Thursday, March 11, 2021

Presentation Time: 12:20 PM ET